-+ 0.00%
-+ 0.00%
-+ 0.00%

Barrington Research Maintains Outperform on Lifecore Biomedical, Raises Price Target to $6

Benzinga·04/29/2026 20:59:37
Listen to the news
Barrington Research analyst Michael Petusky maintains Lifecore Biomedical (NASDAQ:LFCR) with a Outperform and raises the price target from $5.5 to $6.